CN115505386B - 基于bpei和sds的四环素检测材料及其制备方法和应用 - Google Patents
基于bpei和sds的四环素检测材料及其制备方法和应用 Download PDFInfo
- Publication number
- CN115505386B CN115505386B CN202211123208.3A CN202211123208A CN115505386B CN 115505386 B CN115505386 B CN 115505386B CN 202211123208 A CN202211123208 A CN 202211123208A CN 115505386 B CN115505386 B CN 115505386B
- Authority
- CN
- China
- Prior art keywords
- bpei
- sds
- detection material
- tetracycline
- cuncs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000004098 Tetracycline Substances 0.000 title claims abstract description 84
- 235000019364 tetracycline Nutrition 0.000 title claims abstract description 84
- 150000003522 tetracyclines Chemical class 0.000 title claims abstract description 84
- 229960002180 tetracycline Drugs 0.000 title claims abstract description 73
- 229930101283 tetracycline Natural products 0.000 title claims abstract description 73
- 238000001514 detection method Methods 0.000 title claims abstract description 58
- 239000000463 material Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000006185 dispersion Substances 0.000 claims abstract description 57
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 39
- 239000010949 copper Substances 0.000 claims abstract description 34
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 29
- 229910052802 copper Inorganic materials 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 239000011259 mixed solution Substances 0.000 claims abstract description 14
- 229920002873 Polyethylenimine Polymers 0.000 claims abstract description 9
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 8
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 8
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 8
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 6
- 238000001157 Fourier transform infrared spectrum Methods 0.000 claims description 6
- 230000005284 excitation Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 230000008859 change Effects 0.000 abstract description 6
- 238000012795 verification Methods 0.000 abstract description 2
- 239000000843 powder Substances 0.000 description 28
- 229940040944 tetracyclines Drugs 0.000 description 11
- 239000002245 particle Substances 0.000 description 8
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 239000000523 sample Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 238000000695 excitation spectrum Methods 0.000 description 5
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 3
- 229920001213 Polysorbate 20 Polymers 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 238000000862 absorption spectrum Methods 0.000 description 3
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000002189 fluorescence spectrum Methods 0.000 description 3
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002105 nanoparticle Substances 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 3
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000002284 excitation--emission spectrum Methods 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- HFQQZARZPUDIFP-UHFFFAOYSA-M sodium;2-dodecylbenzenesulfonate Chemical compound [Na+].CCCCCCCCCCCCC1=CC=CC=C1S([O-])(=O)=O HFQQZARZPUDIFP-UHFFFAOYSA-M 0.000 description 2
- 241000894007 species Species 0.000 description 2
- SGKRLCUYIXIAHR-AKNGSSGZSA-N (4s,4ar,5s,5ar,6r,12ar)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboxamide Chemical compound C1=CC=C2[C@H](C)[C@@H]([C@H](O)[C@@H]3[C@](C(O)=C(C(N)=O)C(=O)[C@H]3N(C)C)(O)C3=O)C3=C(O)C2=C1O SGKRLCUYIXIAHR-AKNGSSGZSA-N 0.000 description 1
- RXZBMPWDPOLZGW-XMRMVWPWSA-N (E)-roxithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=N/OCOCCOC)/[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 RXZBMPWDPOLZGW-XMRMVWPWSA-N 0.000 description 1
- QKDFWYFCMLUTQD-UHFFFAOYSA-N 17-bromo-N,N-dimethylheptadecan-1-amine Chemical group BrCCCCCCCCCCCCCCCCCN(C)C QKDFWYFCMLUTQD-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- KIPLYOUQVMMOHB-MXWBXKMOSA-L [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O Chemical compound [Ca++].CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O.CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C([O-])[C@]2(O)C(=O)C(C(N)=O)=C1O)C(=O)c1c(O)cccc1[C@@]3(C)O KIPLYOUQVMMOHB-MXWBXKMOSA-L 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- 229960004099 azithromycin Drugs 0.000 description 1
- MQTOSJVFKKJCRP-BICOPXKESA-N azithromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)N(C)C[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 MQTOSJVFKKJCRP-BICOPXKESA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- CYDMQBQPVICBEU-UHFFFAOYSA-N chlorotetracycline Natural products C1=CC(Cl)=C2C(O)(C)C3CC4C(N(C)C)C(O)=C(C(N)=O)C(=O)C4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-UHFFFAOYSA-N 0.000 description 1
- 229960004475 chlortetracycline Drugs 0.000 description 1
- CYDMQBQPVICBEU-XRNKAMNCSA-N chlortetracycline Chemical compound C1=CC(Cl)=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O CYDMQBQPVICBEU-XRNKAMNCSA-N 0.000 description 1
- 235000019365 chlortetracycline Nutrition 0.000 description 1
- LQOLIRLGBULYKD-JKIFEVAISA-N cloxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl LQOLIRLGBULYKD-JKIFEVAISA-N 0.000 description 1
- 229960003326 cloxacillin Drugs 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- XTVVROIMIGLXTD-UHFFFAOYSA-N copper(II) nitrate Chemical compound [Cu+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O XTVVROIMIGLXTD-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- GVGUFUZHNYFZLC-UHFFFAOYSA-N dodecyl benzenesulfonate;sodium Chemical compound [Na].CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 GVGUFUZHNYFZLC-UHFFFAOYSA-N 0.000 description 1
- 229960003722 doxycycline Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000010970 precious metal Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000002096 quantum dot Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960005224 roxithromycin Drugs 0.000 description 1
- 229940080264 sodium dodecylbenzenesulfonate Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940063650 terramycin Drugs 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/08—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials
- C09K11/58—Luminescent, e.g. electroluminescent, chemiluminescent materials containing inorganic luminescent materials containing copper, silver or gold
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y40/00—Manufacture or treatment of nanostructures
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/02—Use of particular materials as binders, particle coatings or suspension media therefor
- C09K11/025—Use of particular materials as binders, particle coatings or suspension media therefor non-luminescent particle coatings or suspension media
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
- C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N21/643—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" non-biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6432—Quenching
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/6428—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes"
- G01N2021/6439—Measuring fluorescence of fluorescent products of reactions or of fluorochrome labelled reactive substances, e.g. measuring quenching effects, using measuring "optrodes" with indicators, stains, dyes, tags, labels, marks
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Materials Engineering (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Optics & Photonics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- Inorganic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Composite Materials (AREA)
- Molecular Biology (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Abstract
本发明公开了基于BPEI和SDS的四环素检测材料及其制备方法和应用,解决了现有技术中铜纳米团簇的荧光变化程度低、检出限高以及特异性和抗干扰性能较差的技术问题。基于BPEI和SDS的四环素检测材料包括铜纳米团簇和附着于铜纳米团簇上的十二烷基硫酸钠;所述铜纳米团簇以支化的聚乙烯亚胺为模板制备得到。制备方法包括以下步骤:(1)获取包括Cu2+、支化的聚乙烯亚胺和抗坏血酸的第一混合液;(2)第一混合液反应一段时间即得到铜纳米团簇分散液;(4)将铜纳米团簇分散液和十二烷基硫酸钠溶液混合,即得到检测材料。经验证,本发明的基于BPEI和SDS的四环素检测材料及其制备方法和应用的实用性强,非常适合于在实际样品的四环素检测中推广使用。
Description
技术领域
本发明涉及四环素检测的技术领域,具体而言,涉及基于BPEI和SDS的四环素检测材料及其制备方法和应用。
背景技术
四环素(TC)长期以来一直用于治疗细菌感染。但是,四环素的过度使用会对环境中的植物以及微生物的成长造成威胁。因此,开发一种高灵敏度、高选择性的检测方法显得尤为重要。之前已经有报道过的多种方法,包括高效液相法、免疫测定、化学发光、液相色谱质谱和荧光法。
荧光法因其低成本、高灵敏度、高选择性等优点已广泛应用于实际样品中物质的检测。近些年关于各种纳米材料的荧光探针,包括量子点、碳点和纳米团簇已被广泛研究,其中,纳米团簇包括银纳米团簇、金纳米团簇以及铜纳米团簇(CuNCs)。目前,金纳米团簇和银纳米团簇研究较早且较为广泛。然而,与贵金属金和银相比,金属铜价格相对便宜且用于合成CuNCs的前体相对丰富、易于获得,因而使得CuNCs在四环素荧光探针的研究中有很大的发展空间。
但是,CuNCs相对于其他的金属纳米团簇,不仅其本身的荧光强度相对过低,并且在实践中发现,CuNCs在对四环素进行检测时的荧光变化程度、检出限高、特异性和抗干扰性能难以满足实际样品中对四环素的检测要求。
发明内容
本发明的主要目的在于提供基于BPEI和SDS的四环素检测材料及其制备方法和应用,以解决现有技术中铜纳米团簇的荧光变化程度低、检出限高以及特异性和抗干扰性能较差的技术问题。
为了实现上述目的,根据本发明的第一个方面,提供了基于BPEI和SDS的四环素检测材料,技术方案如下:
基于BPEI和SDS的四环素检测材料,包括铜纳米团簇和附着于铜纳米团簇上的十二烷基硫酸钠;所述铜纳米团簇以支化的聚乙烯亚胺为模板制备得到。
作为本发明第一方面的进一步改进:所述检测材料的粒度为1.8~3.4nm;所述铜纳米团簇的粒度为0.6~2.4nm。
作为本发明第一方面的进一步改进:所述检测材料的FT-IR光谱在1575cm-1、1472cm-1、2918cm-1和2848cm-1处处具有特征峰,在3100~3600cm-1处具有宽频带的伸缩振动。
作为本发明第一方面的进一步改进:所述检测材料的XPS宽谱图在284.94eV、932.27eV、399.79eV和531.65eV处具有特征峰。
作为本发明第一方面的进一步改进:所述检测材料的激发波长为360nm,发射波长为430nm。
为了实现上述目的,根据本发明的第二个方面,提供了基于BPEI和SDS的四环素检测材料的制备方法,技术方案如下:
上述第一方面所述基于BPEI和SDS的四环素检测材料的制备方法,包括以下步骤:
(1)获取包括Cu2+、支化的聚乙烯亚胺和抗坏血酸的第一混合液;
(2)第一混合液反应一段时间即得到铜纳米团簇分散液;
(4)将铜纳米团簇分散液和十二烷基硫酸钠溶液混合,即得到检测材料。
作为本发明第二方面的进一步改进:所述第一混合液中Cu2+、支化的聚乙烯亚胺和抗坏血酸的摩尔比为1:(8~12):(43~52)。
作为本发明第二方面的进一步改进:第一混合液在18~35℃下震荡反应1-3天即得到铜纳米团簇分散液。
作为本发明第二方面的进一步改进:第一混合液的pH为8~12。
为了实现上述目的,根据本发明的第三个方面,提供了四环素检测方法,技术方案如下:
四环素的检测方法,采用上述第一方面所述检测材料,或采用上述第二方面所述的制备方法制备得到的检测材料。
经验证,本发明的四环素的检测材料和检测方法利用由新型的支化的聚乙烯亚胺(BPEI)和十二烷基硫酸钠(SDS)进行改性的铜纳米团簇对四环素进行检测,成功使得荧光变化程度更明显,并且能够在众多抗生素中特异性识别四环素,并且抗干扰性能优异,线性范围宽,检出限低,非常适合于对四环素进行检测。同时,上述检测材料的制备工艺简单可控,生产效率高。由此可见,本发明的基于BPEI和SDS的四环素检测材料及其制备方法和应用的实用性强,非常适合于在实际样品的四环素检测中推广使用。
下面结合附图和具体实施方式对本发明做进一步的说明。本发明附加的方面和优点将在下面的描述中部分给出,部分将从下面的描述中变得明显,或通过本发明的实践了解到。
附图说明
构成本发明的一部分的附图用来辅助对本发明的理解,附图中所提供的内容及其在本发明中有关的说明可用于解释本发明,但不构成对本发明的不当限定。在附图中:
图1为BPEI-CuNCs-SDS分散液的F0-F随SDS浓度的变化曲线。
图2为检测材料的荧光强度随表面活性剂种类的变化曲线。
图3为四环素溶液的紫外-可见吸收光谱以及BPEI-CuNCs-SDS分散液的荧光激发光谱和发射光谱。
图4为BPEI-CuNCs-SDS分散液和BPEI-CuNCs-SDS+TC的荧光衰减光谱。
图5为BPEI-CuNCs-SDS分散液的F0-F随四环素溶液的pH的变化曲线。
图6为BPEI-CuNCs-SDS分散液的F0-F随反应时间的变化曲线。
图7为BPEI-CuNCs-SDS分散液的F0/F随抗生素种类的变化曲线。
图8为BPEI-CuNCs-SDS分散液的抗干扰性能测试结果。
图9为BPEI-CuNCs-SDS分散液测试不同浓度的四环素溶液的连续荧光光谱图。
图10为BPEI-CuNCs-SDS分散液的F0/F随四环素浓度的变化曲线。
图11为BPEI-CuNCs-SDS分散液的F0/F与四环素浓度(0.5~60μmol/L)的线性校准图。
图12为BPEI-CuNCs-SDS分散液的F0/F与四环素浓度(60~140μmol/L)的线性校准图。
图13为BPEI-CuNCs粉末的TEM照片。
图14为BPEI-CuNCs粉末的粒径分布直方图。
图15为BPEI-CuNCs-SDS粉末的TEM照片。
图16为BPEI-CuNCs-SDS粉末的粒径分布直方图。
图17为SDS、BPEI-CuNCs粉末和BPEI-CuNCs-SDS粉末的红外光谱(FT-IR)。
图18为BPEI-CuNCs-SDS粉末的XPS全谱图。
图19为BPEI-CuNCs-SDS粉末在Cu2p的XPS宽谱图。
具体实施方式
下面结合附图对本发明进行清楚、完整的说明。本领域普通技术人员在基于这些说明的情况下将能够实现本发明。在结合附图对本发明进行说明前,需要特别指出的是:
本发明中在包括下述说明在内的各部分中所提供的技术方案和技术特征,在不冲突的情况下,这些技术方案和技术特征可以相互组合。
此外,下述说明中涉及到的本发明的实施例通常仅是本发明一部分的实施例,而不是全部的实施例。因此,基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都应当属于本发明保护的范围。
关于本发明中术语和单位。本发明的说明书和权利要求书及有关的部分中的术语“包括”、“具有”以及它们的任何变形,意图在于覆盖不排他的包含。
本发明的基于BPEI和SDS的四环素检测材料的制备方法的具体实施方式为包括以下步骤:
(1)获取包括Cu2+、BPEI和抗坏血酸(AA)的第一混合液;
所述第一混合液中Cu2+、AA和BPEI的摩尔比为1:(8~12):(43~52),可以但是不限于取值为1:8:43、1:9:45、1:10:48、1:11:50、1:12:52中的任意一个。
Cu2+由硝酸铜、氯化铜或硫酸铜提供。
第一混合液的pH为8~12,可以但是不限于取值为8、9、10、11、12中的任意一个。
(2)第一混合液在18~35℃下震荡反应1-3天即得到铜纳米团簇分散液(即BPEI-CuNCs分散液);
对BPEI-CuNCs分散液进行冷冻干燥,即可得到BPEI-CuNCs粉末。
(4)在将BPEI-CuNCs分散液和SDS溶液混合后进行超声处理以使溶液均质化,形成BPEI-CuNCs-SDS的分散液,即得到检测材料。
本发明的基于BPEI和SDS的四环素检测材料的具体实施方式为由上述的制备方法制备得到,具体包括BPEI-CuNCs-SDS粉末或BPEI-CuNCs-SDS的分散液,BPEI-CuNCs-SDS粉末由BPEI-CuNCs-SDS的分散液经冷冻干燥得到。所述BPEI-CuNCs-SDS包括铜纳米团簇和附着于铜纳米团簇上的SDS,并且所述铜纳米团簇以BPEI为模板制备得到。
对BPEI-CuNCs-SDS粉末和BPEI-CuNCs粉末进行表征得到:BPEI-CuNCs-SDS的粒度为1.8-3.4nm;BPEI-CuNCs的粒度为0.6~2.4nm;BPEI-CuNCs-SDS的FT-IR光谱在1575cm-1、1472cm-1、2918cm-1和2848cm-1处处具有特征峰,在3100~3600cm-1处具有宽频带的伸缩振动;BPEI-CuNCs-SDS的XPS宽谱图在284.94eV、932.27eV、399.79eV和531.65eV处具有特征峰;BPEI-CuNCs-SDS的激发波长为360nm,发射波长为430nm。
以下通过具体的表征和试验来说明本发明的有益效果。
图1为BPEI-CuNCs-SDS分散液的F0-F随SDS浓度的变化曲线。其中,F0为BPEI-CuNCs-SDS分散液的荧光强度,F为BPEI-CuNCs-SDS+TC(即BPEI-CuNCs-SDS分散液和四环素溶液的混合物)的荧光强度。其它的制备工艺参数为:第一混合液中Cu2+、AA和BPEI的摩尔比为1:10:48.3,将1.73mL硫酸铜溶液(浓度为10mmol/L)、1.73mLAA溶液(浓度为100mmol/L)、36mgBPEI和100mL水混合,然后采用1mol/L的HCl调节pH为10,即得到第一混合液;震荡时间为2天;BPEI-CuNCs-SDS分散液由BPEI-CuNCs分散液和SDS溶液按照体积比为1:1混合而成,BPEI-CuNCs-SDS分散液的体积为200μL。
如图1所示,SDS溶液的最佳浓度为0.6mg/mL。
图2为检测材料的荧光强度随表面活性剂种类的变化曲线。
从图2可以看出,将不同类型的表面活性剂如阳离子表面活性剂(CTAB和CTAC)、阴离子表面活性剂(SDS和SDBS)和非离子表面活性剂(Tween-20和Tween-80)加入到BPEI-CuNCs分散液中,荧光强度相比于BPEI-CuNCs分散液分别增强了1.02、1.67、1.98、1.83、1.49和1.38倍,可见,虽然这些表面活性剂对BPEI-CuNCs都有明显的增强荧光效果,但是SDS的荧光增强效果最佳。其中,每种表面活性剂的浓度相同,CTAB为溴代十六烷基三甲胺,CTAC为十六烷基三甲基氯化铵,SDBS为十二烷基苯磺酸钠,Tween-20为吐温-20,Tween-80为吐温-80。
图3为四环素溶液的紫外-可见吸收光谱以及BPEI-CuNCs-SDS分散液的荧光激发光谱和发射光谱。
导致荧光猝灭的机制主要有光致电子转移(PET)、荧光共振能量转移(FRET)和内滤效应(IFE)。如图3所示,四环素溶液的紫外-可见吸收光谱在300~400nm范围内有吸收峰,与BPEI-CuNCs-SDS分散液的激发光谱重叠,说明四环素诱导的荧光猝灭机制可能是荧光共振能量转移(FRET)或内滤效应(IFE)。由图3可以得到BPEI-CuNCs-SDS分散液的荧光激发光谱的波峰在360nm处,发射光谱的波峰在430nm处。
图4为BPEI-CuNCs-SDS分散液和BPEI-CuNCs-SDS+TC的荧光衰减光谱。
对图4用双指数函数拟合荧光衰减得到BPEI-CuNCs-SDS分散液的平均荧光寿命为3.55ns,BPEI-CuNCs-SDS+TC的平均荧光寿命为3.12ns,因此,BPEI-CuNCs-SDS的荧光被四环素通过FRET机制有效地猝灭。另外,BPEI-CuNCs-SDS的能量会转移到BPEI-CuNCs-SDS和四环素的复合物中,从而使BPEI-CuNCs-SDS的荧光猝灭。
图5为BPEI-CuNCs-SDS分散液的F0-F随四环素溶液的pH的变化曲线。图6为BPEI-CuNCs-SDS分散液的F0-F随反应时间的变化曲线。其中,四环素溶液的pH采用pH为2~7的PBS缓冲液来调节。F0为BPEI-CuNCs-SDS分散液的荧光强度,F为BPEI-CuNCs-SDS+TC的荧光强度。
如图5所示,当四环素溶液的pH为3时,F0-F具有最大值。如图6所示,当BPEI-CuNCs-SDS分散液与四环素溶液的反应时间在5~60min内时,F0-F几乎无变化,为了节约时间,优选反应时间为5min。
图7为BPEI-CuNCs-SDS分散液的F0/F随抗生素种类的变化曲线。F0为BPEI-CuNCs-SDS分散液的荧光强度,F为BPEI-CuNCs-SDS+抗生素的荧光强度。
如图7所示,在四环素、土霉素、强力霉素、金霉素、阿莫西林、诺氟沙星、氧氟沙星、氯苄西林、阿奇霉素、罗红霉素、头孢氨苄中,BPEI-CuNCs-SDS分散液测试四环素的F0/F最大,说明BPEI-CuNCs-SDS能够特异性识别四环素。
图8为BPEI-CuNCs-SDS分散液的抗干扰性能测试结果。F0为BPEI-CuNCs-SDS分散液的荧光强度,F为BPEI-CuNCs-SDS+TC+干扰离子的荧光强度。
如图8所示,在金属离子和阴离子共存的情况下,BPEI-CuNCs-SDS分散液的测试四环素溶液的F0/F几乎没有变化,表明BPEI-CuNCs-SDS对四环素具有良好的抗干扰能力,可以满足实际应用中的要求。
图9为BPEI-CuNCs-SDS分散液测试不同浓度的四环素溶液的连续荧光光谱图。图10为BPEI-CuNCs-SDS分散液的F0/F随四环素浓度的变化曲线。图11为BPEI-CuNCs-SDS分散液的F0/F与四环素浓度(0.5~60μmol/L)的线性校准图。图12为BPEI-CuNCs-SDS分散液的F0/F与四环素浓度(60~140μmol/L)的线性校准图。F0为BPEI-CuNCs-SDS分散液的荧光强度,F为BPEI-CuNCs-SDS+TC的荧光强度。
如图9所示,随着四环素浓度的提升,BPEI-CuNCs-SDS+TC的荧光强度逐渐减小。如图10所示,F0/F与四环素的浓度呈现良好的线性关系,且存在两段线性关系。如图11所示,当四环素浓度为0.5~60μmol/L时,回归方程为:y=0.0352x+0.9328,R2=0.9974;如图12所示,当四环素浓度为60~140μmol/L时,回归方程为:y=0.1279x-4.7842,R2=0.9925。BPEI-CuNCs-SDS分散液检测四环素浓度的检出限为105.3nmol/L,远小于现有技术中的检测限,具有突出优势。
选取西南交通大学校园湖水以及实验室自来水作为实际样品,离心10min后用0.45μm的滤膜过滤,然后向水样中加入四环素形成不同浓度的四环素溶液,采用BPEI-CuNCs-SDS分散液和上述的回归方程测试水样中四环素的浓度。表1显示了BPEI-CuNCs-SDS分散液对实际水样中四环素的检测结果。
表1
从表1可以看出,四环素的回收率在90.1~109.5%范围内,且相对标准偏差(RSD)均小于8.9%,说明BPEI-CuNCs-SDS在实际水样中检测四环素的准确性较高,可以构建新型荧光探针用于快速检测真实样品中的四环素,具有极大的实际应用价值。
在上述的荧光测试中,四环素溶液和抗生素溶液的体积为60μL;四环素溶液浓度作为定量时的浓度为2mmol/L;干扰离子的体积为60μL,浓度为500μmol/L;采用PBS缓冲液将待进行荧光检测的液体体积定容至1.5mL。
图13为BPEI-CuNCs粉末的TEM照片。图14为BPEI-CuNCs粉末的粒径分布直方图。图15为BPEI-CuNCs-SDS粉末的TEM照片。图16为BPEI-CuNCs-SDS粉末的粒径分布直方图。
如图13-16所示,BPEI-CuNCs粉末和BPEI-CuNCs-SDS粉末均由均匀的球形纳米颗粒构成,其中,BPEI-CuNCs粉末由粒度为0.6~2.4nm的纳米颗粒构成,平均粒度为1.54nm,BPEI-CuNCs-SDS粉末由粒度为1.8~3.4nm的纳米颗粒构成,平均粒度为2.62nm。
图17为SDS、BPEI-CuNCs粉末和BPEI-CuNCs-SDS粉末的红外光谱(FT-IR)。
如图17所示,BPEI-CuNCs-SDS粉末的FT-IR光谱显示出SDS的特征峰,说明SDS成功修饰在BPEI-CuNCs表面。在BPEI-CuNCs-SDS粉末的FT-IR光谱中,在1575cm-1处得到的特征峰对应于-NH2和-NH-的弯曲振动,在1472cm-1处的特征峰对应于C-H的收缩振动,在3100~3600cm-1处的宽频带对应于O-H和N-H基团的伸缩振动,在2918cm-1和2848cm-1处的较强特征峰对应于-CH2基团的对称和反对称振动。
图18为BPEI-CuNCs-SDS粉末的XPS全谱图。
如图18所示,在284.94、932.27、399.79和531.65eV处的特征峰分别归因于C1s、Cu2p、N1s和O1s,计算得到BPEI-CuNCs-SDS粉末中C、Cu、N、O的质量分数分别为53.05、0.21、16.80和29.94wt%。
图19为BPEI-CuNCs-SDS粉末在Cu2p的XPS宽谱图。
在图19中,在结合能位于932.3eV和952.1eV处的两个特征峰分别对应于Cu2p3/2和Cu2p1/2,表明BPEI-CuNCs-SDS中铜的价态为零价。
上述表征和性能测试中,荧光光谱在FLS1000稳态/瞬态荧光光谱仪(英国爱丁堡公司)上进行,激发和发射光谱的狭缝宽度为1.5nm。使用PHS-3W pH计(中国上海云赛公司)测量溶液的pH值。K-Alpha+X射线光电子能谱(美国赛默飞公司)用于测试材料的元素组成及价态。USB-2000UV-vis光谱仪(美国海洋光学公司)用于测量材料的吸收特性。使用FEITecnai G2 F20透射电子显微镜(美国)测试所制备的材料的形貌特征。FT-IR采用美国珀金莱默傅里叶变换红外光谱。
以上对本发明的有关内容进行了说明。本领域普通技术人员在基于这些说明的情况下将能够实现本发明。基于本发明的上述内容,本领域普通技术人员在没有做出创造性劳动的前提下所获得的所有其他实施例,都应当属于本发明保护的范围。
Claims (10)
1.基于BPEI和SDS的四环素检测材料,其特征在于:包括铜纳米团簇和附着于铜纳米团簇上的十二烷基硫酸钠;所述铜纳米团簇以支化的聚乙烯亚胺为模板制备得到。
2.如权利要求1所述的基于BPEI和SDS的四环素检测材料,其特征在于:所述检测材料的粒度为1.8~3.4nm;所述铜纳米团簇的粒度为0.6~2.4nm。
3.如权利要求1所述的基于BPEI和SDS的四环素检测材料,其特征在于:所述检测材料的FT-IR光谱在1575cm-1、1472cm-1、2918cm-1和2848cm-1处处具有特征峰,在3100~3600cm-1处具有宽频带的伸缩振动。
4.如权利要求1所述的基于BPEI和SDS的四环素检测材料,其特征在于:所述检测材料的XPS宽谱图在284.94eV、932.27eV、399.79eV和531.65eV处具有特征峰。
5.如权利要求1所述的基于BPEI和SDS的四环素检测材料,其特征在于:所述检测材料的激发波长为360nm,发射波长为430nm。
6.权利要求1-5所述基于BPEI和SDS的四环素检测材料的制备方法,包括以下步骤:
(1)获取包括Cu2+、支化的聚乙烯亚胺和抗坏血酸的第一混合液;
(2)第一混合液反应一段时间即得到铜纳米团簇分散液;
(4)将铜纳米团簇分散液和十二烷基硫酸钠溶液混合,即得到检测材料。
7.如权利要求6所述的制备方法,其特征在于:所述第一混合液中Cu2+、支化的聚乙烯亚胺和抗坏血酸的摩尔比为1:(8~12):(43~52)。
8.如权利要求6所述的制备方法,其特征在于:第一混合液在18~35℃下震荡反应1-3天即得到铜纳米团簇分散液。
9.如权利要求6所述的制备方法,其特征在于:第一混合液的pH为8~12。
10.四环素的检测方法,采用权利要求1-5之一所述检测材料,或采用权利要求6-9之一所述的制备方法制备得到的检测材料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211123208.3A CN115505386B (zh) | 2022-09-15 | 2022-09-15 | 基于bpei和sds的四环素检测材料及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211123208.3A CN115505386B (zh) | 2022-09-15 | 2022-09-15 | 基于bpei和sds的四环素检测材料及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115505386A CN115505386A (zh) | 2022-12-23 |
CN115505386B true CN115505386B (zh) | 2024-03-19 |
Family
ID=84503738
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211123208.3A Active CN115505386B (zh) | 2022-09-15 | 2022-09-15 | 基于bpei和sds的四环素检测材料及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115505386B (zh) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745194A (zh) * | 2015-03-24 | 2015-07-01 | 南昌大学 | 量子点@铜纳米簇比率荧光探针的制备方法及其Cu2+检测应用 |
CN105505382A (zh) * | 2015-12-04 | 2016-04-20 | 安徽师范大学 | 一种铜纳米簇溶液的制备方法及应用 |
CN110596061A (zh) * | 2019-09-19 | 2019-12-20 | 南京林业大学 | 基于BPEI-CuNCs荧光探针快速检测铜离子的方法 |
CN111687408A (zh) * | 2020-06-29 | 2020-09-22 | 太原师范学院 | 一种荧光铜纳米团簇、制备方法及其应用 |
CN114672305A (zh) * | 2022-03-23 | 2022-06-28 | 中电华创电力技术研究有限公司 | 铜纳米团簇荧光探针的制备及水环境中次氯酸根检测方法 |
CN114907837A (zh) * | 2022-05-16 | 2022-08-16 | 山西医科大学 | 一种比率型荧光金铜纳米团簇的制备方法及其产品和应用 |
-
2022
- 2022-09-15 CN CN202211123208.3A patent/CN115505386B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104745194A (zh) * | 2015-03-24 | 2015-07-01 | 南昌大学 | 量子点@铜纳米簇比率荧光探针的制备方法及其Cu2+检测应用 |
CN105505382A (zh) * | 2015-12-04 | 2016-04-20 | 安徽师范大学 | 一种铜纳米簇溶液的制备方法及应用 |
CN110596061A (zh) * | 2019-09-19 | 2019-12-20 | 南京林业大学 | 基于BPEI-CuNCs荧光探针快速检测铜离子的方法 |
CN111687408A (zh) * | 2020-06-29 | 2020-09-22 | 太原师范学院 | 一种荧光铜纳米团簇、制备方法及其应用 |
CN114672305A (zh) * | 2022-03-23 | 2022-06-28 | 中电华创电力技术研究有限公司 | 铜纳米团簇荧光探针的制备及水环境中次氯酸根检测方法 |
CN114907837A (zh) * | 2022-05-16 | 2022-08-16 | 山西医科大学 | 一种比率型荧光金铜纳米团簇的制备方法及其产品和应用 |
Non-Patent Citations (2)
Title |
---|
A Fluorescent Probe Based on Polyethyleneimine Protected Copper Nanoclusters for the Assay of Tetracycline Hydrochloride and Vitamin B12;Yu, WH等;ChemistrySelect;第6卷(第40期);10889-10897 * |
Interaction among branched polyethylenimine (PEI), sodium dodecyl sulfate (SDS) and metal cations during copper recovery from water using polymersurfactant aggregates;Ming Chen等;Journal of Water Process Engineering;第34卷;101170 * |
Also Published As
Publication number | Publication date |
---|---|
CN115505386A (zh) | 2022-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Santhoshkumar et al. | Rationally designed SERS AgNPs/GO/g-CN nanohybrids to detect methylene blue and Hg2+ ions in aqueous solution | |
Zhang et al. | Simple and sensitive detection method for chromium (VI) in water using glutathione—capped CdTe quantum dots as fluorescent probes | |
CN103264165B (zh) | 一种以单链dna为模板合成银纳米簇的方法 | |
Jing et al. | Synthesis and characterization of Ag/polypyrrole nanocomposites based on silver nanoparticles colloid | |
Zhang et al. | Electrochemical clenbuterol immunosensor based on a gold electrode modified with zinc sulfide quantum dots and polyaniline | |
Reyes-Gallardo et al. | Silica nanoparticles–nylon 6 composites: synthesis, characterization and potential use as sorbent | |
Arvand et al. | A new core@ shell silica-coated magnetic molecular imprinted nanoparticles for selective detection of sunset yellow in food samples | |
Dong et al. | Polymerizing dopamine onto Q-graphene scaffolds towards the fluorescent nanocomposites with high aqueous stability and enhanced fluorescence for the fluorescence analysis and imaging of copper ions | |
Wang et al. | Carbon quantum dots embedded mesoporous silica for rapid fluorescent detection of acidic gas | |
Zhang et al. | Synthesis of Ag–Fe 2 O 3–RGO nanocomposites for the electrocatalytic reduction of H 2 O 2 | |
Jiang et al. | A sensitive enzyme-free hydrogen peroxide sensor based on a chitosan–graphene quantum dot/silver nanocube nanocomposite modified electrode | |
Rajabi et al. | Measuring and pre-concentration of lanthanum using Fe3O4@ chitosan nanocomposite with solid-phase microextraction for ICP-OES determination | |
Huang et al. | A sensitive electrochemical sensor based on ion imprinted polymers with gold nanoparticles for high selective detecting Cd (II) ions in real samples | |
CN103043709B (zh) | 一种氧化石墨烯/AgInS2纳米杂化材料的制备方法 | |
Wang et al. | Application of magnetic nanoparticles coated with sodium dodecyl sulfate and modified with 2-(5-bromo-2-pyridylazo)-5-diethyl aminophenol as a novel adsorbent for dispersive-magnetic solid-phase extraction and determination of palladium in soil samples | |
CN106520126B (zh) | 基于掺杂离子发光机制的汞离子探针及其合成方法与应用 | |
Mehrani et al. | Using PVA/CA/Au NPs electrospun nanofibers as a green nanosorbent to preconcentrate and determine Pb 2+ and Cu 2+ in rice samples, water sources and cosmetics | |
CN115505386B (zh) | 基于bpei和sds的四环素检测材料及其制备方法和应用 | |
Lv et al. | The efficient detection of Fe3+ by sulfonamidated lignin composite carbon quantum dots | |
Afsharipour et al. | Chemiluminescence determination of dopamine using N, P-graphene quantum dots after preconcentration on magnetic oxidized nanocellulose modified with graphene quantum dots | |
Han et al. | Simple synthesis of silver nanocluster composites AgNCs@ PE-g-PAA by irradiation method and fluorescence detection of Cr3+ | |
CN113655039A (zh) | 一种基于分子印迹技术构建的微囊藻毒素比率荧光传感器 | |
Zhan et al. | A label-free electrochemical immunosensor based on AuNPs/Zn/Ni-ZIF-8-800@ graphene for the detection of wheat gliadin | |
Zhao et al. | Synthesis of novel chitaline–silica aerogels with spontaneous Au and Ag nanoparticles formation in aerogels matrix | |
Kazemi et al. | Synthesis of a novel molecularly imprinted polymer based on functionalized multi-walled carbon nanotubes for selective extraction of sulfadiazine prior to spectrophotometric determination |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |